Filing Details

Accession Number:
0001209191-21-033986
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-19 16:06:13
Reporting Period:
2021-05-17
Accepted Time:
2021-05-19 16:06:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1847529 Joy Liu C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Svp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-17 65 $215.95 8,300 No 4 S Direct
Common Stock Disposition 2021-05-17 47 $216.88 8,253 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $215.95 (range $215.42 to $216.34).
  3. Ms. Liu undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $216.88 (range $216.43 to $217.21).